ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease (PEG-IFN-SA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01605513
Recruitment Status : Completed
First Posted : May 25, 2012
Last Update Posted : January 26, 2016
Sponsor:
Information provided by (Responsible Party):
Yanhua Ding, First Hospital of Jilin University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2013
  Actual Study Completion Date : December 2013